Optimizing the Time Course of Risks and Benefits of Acute Dual Antiplatelet Therapy for Stroke Prevention

JAMA Neurol. 2022 Aug 1;79(8):736-738. doi: 10.1001/jamaneurol.2022.1230.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aspirin / adverse effects
  • Drug Therapy, Combination
  • Dual Anti-Platelet Therapy
  • Humans
  • Platelet Aggregation Inhibitors* / adverse effects
  • Risk Assessment
  • Secondary Prevention
  • Stroke* / drug therapy
  • Stroke* / prevention & control

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin